Dianthus Therapeutics, Inc. /DE/ Annual Operating Income (Loss) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
  • Dianthus Therapeutics, Inc. /DE/ Operating Income (Loss) for the quarter ending September 30, 2024 was -$29.9M, a 89.7% decline year-over-year.
  • Dianthus Therapeutics, Inc. /DE/ Operating Income (Loss) for the twelve months ending September 30, 2024 was -$82.9M, a 462% decline year-over-year.
  • Dianthus Therapeutics, Inc. /DE/ annual Operating Income (Loss) for 2023 was -$48.2M, a 62.2% decline from 2022.
  • Dianthus Therapeutics, Inc. /DE/ annual Operating Income (Loss) for 2022 was -$29.7M, a 127% decline from 2021.
  • Dianthus Therapeutics, Inc. /DE/ annual Operating Income (Loss) for 2021 was -$13.1M, a 83.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$48.2M -$18.5M -62.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$29.7M -$16.6M -127% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$13.1M +$65.6M +83.4% Jan 1, 2021 Dec 31, 2021 8-K 2023-12-21
2020 -$78.7M +$4.27M +5.14% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-08
2019 -$83M -$23M -38.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-03
2018 -$60M -$24.2M -67.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-03
2017 -$35.7M -$26.5M -285% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-03
2016 -$9.27M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.